Agenus (Formerly known as Antigenics Inc. - Lexington, MA) Reports Third Quarter 2012 Financial Results

LEXINGTON, Mass., Oct. 25, 2012 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN), a biotechnology company working to develop novel immunology based treatments for cancers and infectious diseases, today announced its financial results and business highlights for the third quarter ended September 30, 2012.

Back to news